Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
Launched by ELI LILLY AND COMPANY · Jan 16, 2007
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male
- • History of erectile dysfunction (ED) for at least 3 months duration
- • Anticipate having the same female partner willing to participate throughout the study
- • At least 18 years of age at Visit 1 and agree to make at least 4 sexual attempts during the early phase of the study
- • Adequate partner sexual function as determined by a Female Sexual Function Index
- • Willing to record responses to efficacy questionnaires, sexual quality of life questionnaires and other instruments used in the study
- Exclusion Criteria:
- • May not participate in the study if you have taken tadalafil previously.
- • History of cardiac conditions including angina requiring treatment with nitrates, heart disease of coronary conditions including myocardial infarction, bypass surgery, angioplasty or stent placement for specified time before starting the study.
- • Have sexual partner not willing to complete the scales.
- • Use of nitrates.
About Eli Lilly And Company
Eli Lilly and Company is a global healthcare leader dedicated to creating innovative medicines that improve patient outcomes across a range of therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a rich history of scientific research and a commitment to advancing healthcare, Lilly invests significantly in clinical trials to develop new treatments and enhance existing therapies. The company prioritizes patient safety and ethical standards in its clinical research, fostering collaboration with healthcare professionals and stakeholders to ensure the delivery of high-quality, evidence-based solutions that address unmet medical needs worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
San Antonio, Texas, United States
Knoxville, Tennessee, United States
Lille, , France
Marseille, , France
Newport Beach, California, United States
Stuart, Florida, United States
Huntsville, Alabama, United States
Little Rock, Arkansas, United States
Tampa, Florida, United States
Des Moines, Iowa, United States
Virginia Beach, Virginia, United States
Salzburg, , Austria
Rennes, , France
Augsburg, , Germany
Berlin, , Germany
Hamburg, , Germany
Leverkusen, , Germany
La Joya, , Mexico
Patients applied
Trial Officials
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials